Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Low-cost Parkinson's disease diagnostic test a world first

26.02.2007
Scientists at Melbourne 's Howard Florey Institute have developed a cost-effective diagnostic test for Parkinson's disease (PD), which will also assist researchers to understand the genetic basis of PD and to undertake large-scale studies to identify the genes that cause this debilitating condition.

Currently there is no specific PD diagnostic test and doctors rely on their observations to make a diagnosis, which means some patients may not be prescribed the most suitable medication and around 15% of those diagnosed may actually be suffering from something else.

Whilst conventional DNA sequencing of all six known Parkinson's disease genes is available, this test costs $4,000 and is not covered by Medicare.

Florey research leader, Dr Justin Rubio, has created a ‘ gene-sequencing chip’ that screens 17 genes in all, including the six known Parkinson's disease genes plus some other suspects in one simple test, at a cost of $500.

... more about:
»DNA »Florey »Genetic »Neuron »Parkinson »Rubio »gene-sequencing

Dr Rubio said the gene-sequencing chip would allow for routine testing of people suspected of having Parkinson's disease.

“Around 100,000 Australians have Parkinson's disease but few have had DNA testing for the known genes that cause the disease due to the prohibitive cost,” Dr Rubio said.

“We are now seeking funding to conduct a large-scale trial to examine the effectiveness of our $500 chip compared with the $4,000 DNA test and we are confident our chip will prove to be the better option.

“In addition to providing a genetic diagnosis it is hoped that our chip will eventually be able to pinpoint genetic changes that help to predict a person’s prognosis and even the treatment that best suits them.

“As the test is relatively cheap and only involves collecting a sample of blood or saliva, it could also be made available to the patient's relatives and those at risk of developing PD.

“In addition to being a diagnostic tool, this low-cost chip will allow researchers to undertake an Australia-wide gene-mapping study to identify further genes that are involved in PD.

“More genetic information will deepen our understanding of PD and enable researchers to work towards ways of preventing and treating the disease.

“The successful implementation of this technology could also lead to genetic testing for other diseases ,” Dr Rubio said.

Dr Rubio plans to test the chip on DNA samples from 400 people with PD who were recruited from Victoria and Tasmania, and this project involves collaborators from hospitals and research institutes in both states.

Using the gene-sequencing chip, Dr Rubio and his collaborators now hope to extend the ‘Gene Discovery’ project to all Australian states to determine the genetic basis of PD.

Gene-Sequencing Chip Trial and Australia-Wide Gene-Mapping Study

Although the gene-sequencing chip is not available for clinical use at this stage, people are being sought for both the large-scale gene-sequencing chip trial and the Australiawide gene-mapping study.

To be eligible for the trial and /or study you must have either:

Developed PD symptoms under the age of 40 AND/OR
At least three or more close relatives (grandparents, parents, brother/sister, offspring, first cousin).

If you fit the above criteria, the Florey would welcome your participation. To participate you must:

Ask your neurologist if it is OK to participate and if your neurologist will provide the Florey your clinical information (you will need to provide written consent to your neurologist to do this) AND
Fill out a questionnaire and provide us with a sputum sample AND
Be willing for the Florey to subsequently see you to perform a clinical assessment.

For more information about the trial and study phone (03) 8344 1888 or visit www.hfi.unimelb.edu.au

WHAT IS PARKINSON’S DISEASE?

Parkinson’s disease (PD) is a common neurological condition with 1% of people affected over the age of 60. In PD, there is a progressive loss of neurons located in an area of the brain called the substantia nigra. Under normal circumstances, these neurons communicate via an important chemical messenger called dopamine. The continual loss of dopamine neurons disrupts communication throughout the entire brain and prevents it from being able to prepare and coordinate the series of commands involved in physical movement.

WHAT ARE THE SYMPTOMS?

By the time PD symptoms show, an estimated 60 to 80% of the dopamine neurons have died. The four main symptoms associated with PD are:

Tremor
Muscular rigidity
Slowness in movement
Postural instability or stooped posture.
AUSTRALIAN STATISTICS
There are about 100,000 Australians with PD
In Victoria there are over 25,000 people with Parkinson’s
Around 19 people are diagnosed with PD each week in Victoria
1 in 7 Australians with PD are under the age of 50
FAST FACTS
Parkinson’s is a manageable condition
30% of people diagnosed with Parkinson’s are of working age
About 1 in 10 of those diagnosed are under 40
Several high-profile celebrities have been affected by Parkinson’s, such as Don Chipp, Michael J. Fox, Mohammad Ali, and Pope John Paul

The Howard Florey Institute is Australia’s leading brain research centre. Its scientists undertake clinical and applied research that can be developed into treatments to combat brain disorders, and new medical practices. Their discoveries will improve the lives of those directly, and indirectly, affected by brain and mind disorders in Australia, and around the world. The Florey’s research areas cover a variety of brain and mind disorders including Parkinson’s disease, stroke, motor neuron disease, addiction, epilepsy, multiple sclerosis, autism and dementia.

Merrin Rafferty | EurekAlert!
Further information:
http://www.hfi.unimelb.edu.au

Further reports about: DNA Florey Genetic Neuron Parkinson Rubio gene-sequencing

More articles from Life Sciences:

nachricht Researchers develop eco-friendly, 4-in-1 catalyst
25.04.2017 | Brown University

nachricht Transfecting cells gently – the LZH presents a GNOME prototype at the Labvolution 2017
25.04.2017 | Laser Zentrum Hannover e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

NASA's Fermi catches gamma-ray flashes from tropical storms

25.04.2017 | Physics and Astronomy

Researchers invent process to make sustainable rubber, plastics

25.04.2017 | Materials Sciences

Transfecting cells gently – the LZH presents a GNOME prototype at the Labvolution 2017

25.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>